The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Jul. 22, 2020
Applicant:

Sun Pharma Advanced Research Company Limited, Maharashtra, IN;

Inventors:

Rajan Kumar Pal, Vadodara, IN;

Biswajit Samanta, Vadodara, IN;

Jayraj Dilipbhai Aradhye, Vadodara, IN;

Sandeep Pankajkumar Pathak, Vadodara, IN;

Kaushik Dhanjibhai Prajapati, Vadodara, IN;

Bhavesh Mohanbhai Panchal, V.V. Nagar, IN;

Trinadha Rao Chitturi, Vadodara, IN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 405/10 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 405/10 (2013.01); A61P 35/00 (2018.01);
Abstract

A selective estrogen receptor degrader (SERD), a compound 3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, and its S enantiomer, (2S)-3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, or pharmaceutically acceptable salts thereof. Also provided are processes for their preparation. Also provided for is the use of these compounds for the treatment of diseases which are related to modulation of estrogen receptors, such as ER-positive breast cancer.


Find Patent Forward Citations

Loading…